Search - tctmd.com

Displaying 361 - 380 of 544

Sort: Relevancy | Date

News Daily News

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

Todd Neale

April 01, 2016

News Daily News

Cirugía de válvula mitral mínimamente invasiva da buenos resultados sin aumentar los costos

Todd Neale

April 01, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

News Conference News CRT 2016

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

Shelley Wood

February 25, 2016

News Industry News

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

February 21, 2016

News Conference News CRT 2016

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Shelley Wood

February 21, 2016

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

News Industry News

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

January 10, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

L.A. McKeown

December 21, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Daily News

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

Michael O'Riordan

December 06, 2015

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

News Industry News

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

December 02, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

November 22, 2015

Advertisement

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

Cirugía de válvula mitral mínimamente invasiva da buenos resultados sin aumentar los costos

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content